Moreover patients with AHA showed a trend towards a worse response rate to antilymphoma treatments and were apparently characterized by a reduced overall survival, although one may speculate that this finding represents just a surrogate of the worse prognosis correlated to both T-cell phenotype and paraproteinemia.
← all excerpts
Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas.
1
—
—